Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2028821000168117 | Kanuma (sebelipase alfa 2 mg / 1 mL) injection solution, 1 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2028831000168119 | Kanuma 2 mg/mL injection solution, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Kanuma 2 mg/mL injection solution, vial | Is a | trade product unit of use | false | Inferred relationship | Some | ||
Kanuma 2 mg/mL injection solution, vial | Is a | Kanuma | false | Inferred relationship | Some | ||
Kanuma 2 mg/mL injection solution, vial | Is a | sebelipase alfa 2 mg/mL injection, vial | false | Inferred relationship | Some | ||
Kanuma 2 mg/mL injection solution, vial | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
Kanuma 2 mg/mL injection solution, vial | has unit of use | vial | false | Inferred relationship | Some | ||
Kanuma 2 mg/mL injection solution, vial | has intended active ingredient | sebelipase alfa | false | Inferred relationship | Some | 1639466928 | |
Kanuma 2 mg/mL injection solution, vial | has Australian BoSS | sebelipase alfa | false | Inferred relationship | Some | 1639466928 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Kanuma (sebelipase alfa 2 mg / 1 mL) injection solution, 1 x 1 mL vial (trade product pack) | has TPUU | False | Kanuma 2 mg/mL injection solution, vial | Inferred relationship | Some | |
Kanuma 2 mg/mL injection solution, 1 mL vial | has TPUU | False | Kanuma 2 mg/mL injection solution, vial | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set